Skip to main content
Biofrontera AG logo

Biofrontera AG — Investor Relations & Filings

Ticker · B8F ISIN · DE000A4BGGM7 LEI · 391200D6GFSVFGFQTL13 F Manufacturing
Open in API
Filings indexed 120 across all filing types
Latest filing 2012-03-28 Report Publication Anno…
Country DE Germany
Listing F B8F

About Biofrontera AG

https://www.biofrontera.com/en/

Biofrontera AG is a biopharmaceutical company that specializes in dermatology. The company develops and markets innovative products for the treatment, care, and protection of the skin. Its core expertise is in photodynamic therapy (PDT), a non-invasive treatment for various skin conditions. Biofrontera's products are primarily focused on treating forms of non-melanoma skin cancer, such as actinic keratosis, field cancerization, and basal cell carcinoma. The portfolio includes both dermatological drugs and medical cosmetics.

Recent filings

Filing Released Lang Actions
Datum:28.03.2012
Report Publication Announcement Classification · 100% confidence The document is a short notification (approx. 1000 characters) announcing the publication and availability of the 2011 Annual Financial Report for Biofrontera AG. It provides a link to the report rather than containing the report itself. Per the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA).
2012-03-28 German
Hinweias auf Zwischenmitteilung
Report Publication Announcement Classification · 100% confidence The document is a short announcement (under 1,000 characters) that informs the public about the publication of a financial report (Zwischenmitteilung for Q3 2011). It provides a link to the report and specifies the publication date, rather than containing the report itself. Following the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA).
2011-11-16 German
Datum:02.09.2011
Audit Report / Information Classification · 100% confidence The document is a formal 'Bestätigungsvermerk des Abschlussprüfers' (Auditor's Report) for Biofrontera AG for the fiscal year 2008. It details the scope of the audit, the auditor's opinion, and includes a specific section on the company's going concern status and liquidity planning. As it is a standalone audit report and not the full annual report itself, it falls under the Audit Report category. FY 2008
2011-09-02 German
Halbjahresfinanzbericht
Report Publication Announcement Classification · 100% confidence The document is a short announcement (under 1,000 characters) stating that the company's half-year financial report has been published and provides a link to access it. Per the 'Menu vs Meal' rule, this is an announcement of a report rather than the report itself, making it a Report Publication Announcement (RPA).
2011-08-23 German
Datum:11.05.2011
Report Publication Announcement Classification · 100% confidence The document is a short announcement (958 characters) from Biofrontera AG stating that a quarterly financial report has been published and providing a link to access it. According to the 'Menu vs Meal' rule, since this is an announcement of a report rather than the report itself, it is classified as a Report Publication Announcement (RPA).
2011-05-11 German
Datum:05.05.2011
Annual Report Classification · 100% confidence The document is a 'Jahresabschluss' (Annual Financial Statement) and 'Zusammengefasster Lage- und Konzernlagebericht' (Combined Management and Group Management Report) for Biofrontera AG for the fiscal year 2010. It contains detailed financial information, business strategy, research and development updates, and patent developments. As it is a comprehensive annual report covering the full fiscal year, it is classified as a 10-K (Annual Report). FY 2010
2011-05-05 German

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.